Jae Hyung Park
Interventional Pain Medicine · Sun City, AZNPI 1255727889
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Abbott at 51.7% of the total. Reporting peaked in 2023 at $7,819 and has fallen 71.0% since, to $2,268 in 2025.
Across 349 payments — averaging $47.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$9K
- Boston Scientific$2K
- Medtronic$2K
- Relievant Medsystems, Inc.$1K
- Biotronik NRO, Inc.$797
- Painteq LLC$547
- plus $2K from 19 others
What the payments were for
- Travel & lodging$6,48539%
- Food & beverage$9,71059%
- Education$3662%
- Entertainment$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 201 | $8,568 |
| Boston Scientific | 51 | $2,084 |
| Medtronic(2 entities) | 24 | $1,785 |
| Relievant Medsystems, Inc. | 4 | $1,080 |
| Biotronik NRO, Inc. | 19 | $797 |
| Painteq LLC | 10 | $547 |
| Vertos Medical, Inc. | 4 | $356 |
| Spinal Simplicity, LLC | 5 | $250 |
| Globus Medical | 2 | $201 |
| Spinefrontier, Inc. | 1 | $200 |
| Nevro Corp. | 4 | $177 |
| Acacia Pharma Inc | 1 | $121 |
| AbbVie(2 entities) | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 4 | $63 |
| Bioventus LLC | 2 | $40 |
| Vertex | 2 | $38 |
| Surgical Specialties Corporation (US), Inc. (dba Corza Medical) | 1 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Foundation Fusion Solutions, LLC | 2 | $22 |
| Protega Pharmaceutials Inc | 1 | $21 |
| Electronic Waveform Lab, Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,564
- Intracept$4,478
- SPECTRA WAVEWRITER$1,038
- Prospera$503
- INTELLIS ADAPTIVESTIM$421
- mild Device Kit$321
- INTELLIS$299
- PAINTEQ$225
- InSpan$200
- SIJFuse$200
- NanoFuse$200
- OCTRODE$176
- ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$175
- HA MINUTEMAN G3-R$168
- INCEPTIV$167
- Omnia$127
- BYFAVO$121
How this compares
$16,578 in reported general payments places this provider in the 70th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 388 | $7,864 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 312 | $7,273 |
| Xtampza ErOxycodone Myristate | 11 | $5,765 |
| Pregabalin | 188 | $3,399 |
| Oxycodone Hcl | 183 | $2,789 |
| Gabapentin | 218 | $2,682 |
| Duloxetine Hcl | 83 | $1,239 |
| Cyclobenzaprine Hcl | 78 | $1,055 |
| Morphine Sulfate ErMorphine Sulfate | 45 | $924 |
| Tramadol Hcl | 144 | $749 |
| Naproxen Sodium | 12 | $742 |
| Baclofen | 23 | $631 |
| Diclofenac Sodium | 19 | $626 |
| Nabumetone | 40 | $593 |
| Tizanidine Hcl | 49 | $581 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $63 | $5,76511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 64 interventional pain medicine providers in Arizona.
Other interventional pain medicine in Sun City
- Clifford BakerSun City$25K
- David TomSun City$4K
- Paul LynchScottsdale$283K
- Jack DiepLake Havasu City$233K
- Matthew RansonMesa$86K
- Steven SiwekPhoenix$57K
- Ajay YedduGilbert$52K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Sachin NarainGilbert$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.